← Open Payments lookup

DANIEL CHUEH: Open Payments

NPI 1174589642 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$15,440 in 102 payments from 14 companies in 2025. Trend: 2023 $18,130 · 2024 $36,363 · 2025 $15,440

Speaker / faculty: $10,041Food & beverage: $2,742Consulting: $2,646Travel & lodging: $12
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$11,854
Otsuka America Pharmaceutical, Inc.11$1,558
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$554
E.R. Squibb & Sons, L.L.C.12$275
ABBVIE INC.8$185
Alkermes, Inc.4$180
Axsome Therapeutics, Inc.3$174
Vanda Pharmaceuticals Inc.12$174
Otsuka Pharmaceutical Development & Commercialization, Inc.2$154
Janssen Pharmaceuticals, Inc1$144

Products named: UZEDY, REXULTI, CAPLYTA, COBENFY, VRAYLAR, Auvelity, FANAPT, SPRAVATO.

Industry payments across CA — which companies pay providers there.